Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.32 USD | -1.74% | -8.33% | +39.02% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.02% | 2.21B | |
+32.35% | 49.46B | |
+2.28% | 42.58B | |
+49.11% | 42.49B | |
-5.26% | 29.09B | |
+12.58% | 26.61B | |
-23.62% | 18.64B | |
+8.46% | 13.16B | |
+30.52% | 12.55B | |
+24.15% | 12.1B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Truist Ups Price Target on Kymera Therapeutics to $54 From $41, Keeps Buy Rating